Elevated CSF GAP‐43 is Alzheimer's disease specific and associated with tau and amyloid pathology-Reference-Cited by-同舟云学术

Elevated CSF GAP‐43 is Alzheimer's disease specific and associated with tau and amyloid pathology

Published:2018-10-12 Issue:1 Volume:15 Page:55-64
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Sandelius Åsa¹,Portelius Erik¹²,Källén Åsa²,Zetterberg Henrik¹²³⁴,Rot Uros⁵,Olsson Bob¹²,Toledo Jon B.⁶⁷,Shaw Leslie M.⁶,Lee Virginia M. Y.⁶,Irwin David J.⁶,Grossman Murray⁸,Weintraub Daniel⁸⁹¹⁰,Chen‐Plotkin Alice⁸,Wolk David A.⁸,McCluskey Leo⁸,Elman Lauren⁸,Kostanjevecki Vesna¹¹,Vandijck Manu¹¹,McBride Jennifer⁶,Trojanowski John Q.⁶,Blennow Kaj¹²

Affiliation:

1. Institute of Neuroscience and PhysiologyDepartment of Psychiatry and NeurochemistryThe Sahlgrenska Academy at the University of GothenburgMölndalSweden

2. Clinical Neurochemistry LaboratorySahlgrenska University HospitalMölndalSweden

3. UK Dementia Research InstituteLondonUK

4. Department of Molecular NeuroscienceUCL Institute of NeurologyLondonUK

5. Department of NeurologyUniversity Medical CentreLjubljanaSlovenia

6. Department of Pathology and Laboratory MedicineInstitute on AgingCenter for Neurodegenerative Disease ResearchUniversity of Pennsylvania School of MedicinePhiladelphiaPAUSA

7. Department of NeurologyHouston Methodist HospitalHoustonTXUSA

8. Department of NeurologyUniversity of Pennsylvania School of MedicinePhiladelphiaPAUSA

9. Department of PsychiatryUniversity of Pennsylvania School of MedicinePhiladelphiaPAUSA

10. Parkinson's Disease and Mental Illness ResearchEducation and Clinical Centers (PADRECC and MIRECC)Philadelphia Veterans Affairs Medical CenterPhiladelphiaPAUSA

11. Fujirebio Europe nvGhentBelgium

Funder

Avid Radiopharmaceuticals

Eli Lilly

Merck

Functional Neuromodulation

Biogen

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2018.08.006

Reference43 articles.

1. CSF biomarkers cutoffs: the importance of coincident neuropathological diseases

2. Pathological α-synuclein distribution in subjects with coincident Alzheimer’s and Lewy body pathology

3. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

4. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

5. The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polygenic hazard score predicts synaptic and axonal degeneration and cognitive decline in Alzheimer's disease continuum;Archives of Gerontology and Geriatrics;2024-12

2. Identification of the Shared Gene Signatures Between Alzheimer’s Disease and Diabetes-Associated Cognitive Dysfunction by Bioinformatics Analysis Combined with Biological Experiment;Journal of Alzheimer's Disease;2024-09-10

3. Navigating the Landscape of Plasma Biomarkers in Alzheimer's Disease: Focus on Past, Present, and Future Clinical Applications;Neurology and Therapy;2024-09-07

4. Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: an update of the literature;Expert Review of Neurotherapeutics;2024-09-04

5. Altered brain connectivity in mild cognitive impairment is linked to elevated tau and phosphorylated tau, but not to GAP-43 and Amyloid-β measurements: a resting-state fMRI study;Molecular Brain;2024-08-30